Ticker Scorecard - MDGL Basics Company: Madrigal Pharmaceuticals, Inc. IPO Date: February 6, 2007 Sector: Healthcare Industry: Biotech Market Cap: $7.33B Activated in VL: True Average Daily Range Avg Daily Range: $3.41 | 2.61% Avg Daily Range (30 D): $10.28 | 3.21% Avg Daily Range (90 D): $8.09 | 2.65% Institutional Daily Volume Avg Daily Volume: .21M Avg Daily Volume (30 D): .34M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 46 Avg Trade Size (Sh.) (30 D): 35 Avg Trade Size (Sh.) (90 D): 34 Institutional Trades Total Inst.Trades: 2,099 Avg Inst. Trade: $5.25M Avg Inst. Trade (30 D): $12.33M Avg Inst. Trade (90 D): $11.18M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.51M Avg Closing Trade (30 D): $13.41M Avg Closing Trade (90 D): $12.48M Avg Closing Volume: 31.59K     News Feb 12, 2025 @ 1:00 PM Madrigal Pharmaceuticals to Release Fourth-Quarter... Source: N/A Feb 2, 2025 @ 11:21 PM This Stock Just Doubled in 1 Day -- Is It Still a ... Source: Prosper Junior Bakiny Jan 17, 2025 @ 1:28 PM Why Madrigal Pharmaceuticals Stock Was Plummeting ... Source: Eric Volkman Jan 13, 2025 @ 4:20 PM Why Madrigal Pharmaceuticals Stock Is Sinking Toda... Source: Keith Speights Jan 3, 2025 @ 1:00 PM Madrigal Pharmaceuticals to Present at the 43rd An... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-4.92 $-7.1 $-7.38 Diluted EPS $-4.92 $-7.1 $-7.38 Revenue $ 62.18M $ 14.64M $ M Gross Profit $ $ $ Net Income / Loss $ -106.96M $ -151.97M $ -147.54M Operating Income / Loss $ -116.3M $ -162.54M $ -152.04M Cost of Revenue $ $ $ Net Cash Flow $ -261.91M $ -122.92M $ 522.6M PE Ratio     Splits Jul 25, 2016:   35:1